The global automated endoscope reprocessors market was valued at US$ 408.6 Mn in 2021. Sales of automated endoscope reprocessors are expected to reach US$ 843.1 Mn by 2032, increasing at 6.9% CAGR. European sales of automated endoscope reprocessors are expected to register 7.6% CAGR through 2032.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/5333  

Demand for automated endoscope reprocessors is growing due to increased awareness regarding hospital-acquired infections at healthcare facilities for staff as well as patient safety. Furthermore, the emergence of many epidemics, including the current COVID-19 pandemic, and its looming health dangers, has boosted demand for automated endoscope reprocessors (AER) among both, the general public and healthcare professionals, thereby supporting market growth.

Greater emphasis on the importance of training, oversight, and competence testing for the staff involved in endoscope reprocessing is of prime importance, according to FDA. To achieve high-level disinfection, all staff members at endoscopy reprocessing units are advised to undergo documented brand and model-specific training once a year. Such training programs enhance users’ ability to efficiently and effectively commence the reprocessing procedure, thus achieving a high level of sterilization for endoscopes.

Furthermore, for any change in the reprocessing guidelines issued by regulatory bodies, there is an utmost requirement of updated evaluation and documentation of competency. This enhances the overall AER reprocessing effectiveness. Additionally, the incorporation of quality programs for training staff, such as specific written procedures, including monitoring the cleaning and reprocessing protocols and records of institutional compliance, is beneficial.

Key market players are focusing on novel product development with enhanced efficacy in terms of environmental stability, protection from infections, and durability.

Company Profiles:

• STERIS
• Olympus Corporation
• ASP
• Getting AB
• HOYA Corporation
• Ecolab Inc.
• Custom Ultrasonics, Inc.
• ARC Group of Companies Inc.
• SHINVA MEDICAL INSTRUMENT CO., LTD.
• Ottomed Endoscopy

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/5333  

Key Takeaways from Market Study

• Dual basin automated endoscope reprocessors held approximately 50.7% market value share in 2021 owing to their property of monitoring a step-by-step process during the reprocessing of endoscopes.
• Standalone automated endoscopic reprocessors are set to lead in terms of usage with a projected market value share of around 87.4% by 2032.
• North America is considered the leading market with a value share of 34.8% expected for 2032.

“Rising initiatives to promote health safety products, as well as increasing adoption of endoscope reprocessor units at healthcare facilities, is set to propel global market growth,” says an analyst of Persistence Market Research.

Market Competition

While automated endoscope reprocessor manufacturers are operating at full capacity, demand has outstripped supply since the emergence of COVID-19 in 2020. A substantial array of end users, particularly healthcare providers and other industrial users, have been affected by this gap.

The market for automated endoscope reprocessors is consolidated and there exist a number of local, emerging, as well as established players. Key players have initiated promotional activities to introduce the design and engineering of novel automated endoscope reprocessors with enhanced efficacy.

• On March 8, 2022, Johnson and Johnson was selected as one of the Fast Company’s Most Innovative Companies for 2022, recognizing it in the health category for driving innovations in latest devices, services, and approaches to empower patients.
• On May 31, 2021, PENTAX Medical and Jiangsu Vedkang Medical Science and Technology Co., Ltd. (Vedkang) entered into a joint venture agreement.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the automated endoscope reprocessors market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/5333

The research study is based on the product (single basin automated endoscopic reprocessors and dual basin automated endoscopic reprocessors), modality (standalone automated endoscopic reprocessors and table/bench top automated endoscopic reprocessors), and end user (hospitals, ambulatory surgical centers, specialty clinics), across seven key regions of the world.

About Us: Persistence Market Research

Contact Us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com